AI Regulation for Medical Devices in Europe: the 2027 Position. What applies, what does not, and what the year is actually for.

The high-risk obligations arrive through Annex I, which puts them in 2028. Everything that can stop you selling arrives before then.

The three dates that govern your year

31 December 2027 — the MDR transitional period ends for Class III and Class IIb implantable devices, subject to the stated exceptions. A product that cannot stay on the market has no AI Act problem.

28 January 2028 — the deadline for notified bodies already designated under the MDR or IVDR to apply for AI Act designation. Designation is granted by scope, not in general, so the queue forms during 2027.

2 August 2028 — the AI Act’s high-risk obligations reach medical devices, through Annex I. MDCG 2025-6 says 2 August 2027. It is still the operative guidance on the MDR, IVDR and AI Act interplay, and it was written before the Digital Omnibus moved the date.

What the paper gives you

  • Which of your devices are high-risk and which are not. Article 6(1) reads off your existing MDR or IVDR class. Class I without a sterile, measuring or reusable surgical aspect is out. Class IIa upward is in. The table is in Title I.
  • The Annex III trap most manufacturers have not checked. Article 6(2) is cumulative with 6(1), so a triage or prioritisation function can pull a 2 December 2027 date onto a device you have scheduled for 2028.
  • What to ask your notified body, and when. Whether they intend to apply before 28 January 2028, and for which scope. A body without the right scope is a change of notified body, not a scheduling problem.

Written by Yuliia Habriiel LL.B., AIGP, European Compliance Suite. Regulatory and conformity analysis, not legal advice.

Get access to the report (PDF, instant access):